SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : 2024 Biotech Charity Contest

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: technetium who wrote (70)5/13/2024 11:51:33 AM
From: technetium  Read Replies (2) of 100
 
Honestly, I thought it more likely than not that this week would see the pendulum swing back again, but it isn’t horrible, such that the net for the last two weeks is still a significant plus. So this week while the NASDAQ composite cooled to just a 1% gain, both the biotech indices were negative, enough to again move their YTD performances back into the red.

Probably the biggest news for biotechs this week was NVAX’s announcement Friday of a huge licensing agreement with Sanofi, with half a billion dollars in cash upfront, and an additional $700 million based on meeting a number of milestones. The agreement will include the commercialization of a combined Covide-19 and flu shot, and give Sanofi a minority holding in NVAX. This resulted in a weekly gain of +82% of its original price at the start of the contest, with almost all the activity on Friday. It also managed to put the big squeeze on what is among the most heavily shorted stocks in the US.

DSGN gained +32% for the week in response to their first quarter financials and releasing a discussion of upcoming expectations. PSTV was up +21% after announcing a private placement of up to $18 million. ZLAB added +14% with the release of first quarter financials, and the Aussies of CU6.AX gained another +12.5% for the week, adding to last week’s gains to put them in fifth place for their YTD performance of +99%.

This week’s big loser was GLYC (-66%) after announcing a failed Phase III trial, making it the worst holding YTD as well, -89%. VERU (-42%) and JSPR (-40%) gave back almost all of their gains of the previous week, dropping VERU from the top five YTD performers. IOVA’s first quarter earnings beat expectations, though the report’s lagging sales numbers may have resulted in the -33% drop. ENTA’s earnings report also disappointed to the tune of a -27% loss for the week.

Overall the contest portfolios shed -$4.6k on average, but the average YTD return is still in the black (+$7.9k), just under the NASDAQ composite's YTD return of +$8.9k.

Only three portfolios managed a positive return for the week, though YTD ten contestants ae still in the black. TOMATO had the best return, +$5.4k, as the only portfolio with a position in NVAX. This brought TOMATO up two spots in the YTD rankings to eighth place (+$7.6k). Likewise, STEVE LOKNESS was in second for the week (+$1.9k), the sole holder of DSGN.

Besides TOMATO every other of the top eight YTD contestants were in the red for the week, so changes in the rankings were more a matter of who had a less bad week. BLADERUNNER had the worst week, (-$22k), with holdings in GLYC, JSPR, and IOVA, but stayed in the number two spot YTD, even though the gap between them and number one BULBAMAN increased to $30k. RAJU_BIJLEE, another holder of both GLYC and IOVA, dropped from third to fourth, changing places with ERIKOTTO.

Report Time Ranges











From

To

















Recent

5/3/24

5/10/24

















YTD

12/31/2023









Index Portfolios’ Performance









Symbol

Recent P/L

Recent %

YTD P/L

















^IXIC

$1,229.34

1.1%

$8,856.73

















^NBI

-$1,137.24

-1.1%

-$964.31

















^SPSIBI

-$2,284.66

-2.3%

-$1,314.37









Share Performance

Recent Performance

YTD Performance



Top Five



Bottom Five



Top Five



Bottom 5

Symbol

P/L / Initial Price

Symbol

P/L / Initial Price

Symbol

YTD P/L / Initial Price

Symbol

YTD P/L/ Initial Price

NVAX

82.3%

GLYC

-66.2%

VKTX

295.7%

GLYC

-88.7%

DSGN

32.1%

VERU

-41.7%

JSPR

170.3%

AMLX

-88.1%

PSTV

20.6%

JSPR

-40.4%

PYXS

141.1%

CNSP

-84.6%

ZLAB

14.0%

IOVA

-32.8%

CRDF

129.1%

PACB

-82.0%

CU6.AX

12.5%

ENTA

-26.8%

CU6.AX

99.0%

EYEN

-62.9%

Average and Median Portfolio Performance



Recent P/L







YTD P/L







Avg.

Median







Avg

Median







-$4,612.99

-$1,953.47

DART LANZER



$7,899.15

$5,715.09

JACK HARTMANN

Top Seven Portfolio Performances

Top Recent Performers

Top YTD Performers

Contestant (Prev. Rank)

Recent P/L

P/L vs. ^SPSIBI

YTD P/L (Rank)

Contestant (Prev. Rank)

YTD P/L

vs. Top Portfolio

P/L vs. ^SPSIBI

Rec. P/L (Rank)

1 - TOMATO (10)

$5,389.00

$7,673.66

$7,643.44 (8)

1 - BULBAMAN (1)

$73,590.79

——

$74,905.16

-$2,002.07 (10)

2 - STEVE LOKNESS (11)

$1,873.13

$4,157.79

-$767.12 (11)

2 - BLADERUNNER (2)

$43,898.33

$29,692.46

$45,212.70

-$22,068.04 (17)

3 - ALONER (17)

$80.02

$2,364.68

-$8,675.32 (14)

3 - ERIKOTTO (4)

$22,149.45

$51,441.34

$23,463.83

-$7,559.00 (13)

4 - TRACE I11 (13)

-$72.62

$2,212.04

$10,860.45 (6)

4 - RAJU_BIJLEE (3)

$17,520.13

$56,070.66

$18,834.50

-$15,718.03 (16)

5 - JACK HARTMANN (8)

-$688.90

$1,595.76

$5,715.09 (9)

5 - TECHNETIUM (6)

$12,376.71

$61,214.08

$13,691.08

-$6,358.56 (12)

6 - KATHLEEN (4)

-$1,081.68

$1,202.98

$1,997.82 (10)

6 - TRACE I11 (7)

$10,860.45

$62,730.33

$12,174.83

-$72.62 (4)

7 - A. J. MULLEN (14)

-$1,217.63

$1,067.03

-$23,612.00 (17)

7 - DEW_DILIGENCE (5)

$9,214.71

$64,376.08

$10,529.09

-$12,453.22 (15)

8 - NOTABOT (15)

-$1,901.80

$382.86

-$8,671.88 (13)

8 - TOMATO (10)

$7,643.44

$65,947.35

$8,957.81

$5,389.00 (1)

Top Portfolios’ Contents

Top Recent Performance Portfolio (TOMATO)

Top YTD Performance Portfolio (BULBAMAN)

Symbol (Rank)

Initial Allocation

Value/Total | ROI

YTD Stock P/L

Recent Stock P/L

% Current Price Change for $1,000 P/L

Symbol (Rank)

Initial Allocation

Value/Total | ROI

YTD Stock P/L

Recent Stock P/L

% Current Price Change for $1,000 P/L

BTAI

10.00%

6.6% | -29.2%

-$2,915.25

-$1,627.12

14.1%

CU6.AX

20.00%

22.9% | 99.0%

$19,800.07

$2,502.02

2.5%

CCCC

10.00%

10.1% | 9.0%

$902.65

-$1,026.55

9.2%

CYTH

10.00%

5.3% | -7.5%

-$754.72

-$251.57

10.8%

HROW

20.00%

19.2% | 3.6%

$714.29

$2,178.57

4.8%

LRMR

10.00%

9.0% | 56.5%

$5,648.35

-$1,417.58

6.4%

NVAX

10.00%

17.2% | 85.0%

$8,500.00

$8,229.17

5.4%

PMN

10.00%

9.5% | 64.3%

$6,434.78

-$608.70

6.1%

NVCT

10.00%

7.1% | -23.3%

-$2,326.14

-$2,086.33

13.0%

SNGX

10.00%

3.0% | -47.5%

-$4,751.32

-$73.68

19.1%

OCUL

10.00%

11.8% | 26.9%

$2,690.58

-$1,143.50

7.9%

TCON

10.00%

3.2% | -44.9%

-$4,488.86

$199.89

18.1%

TARA

10.00%

14.9% | 60.0%

$5,999.15

$479.97

6.3%

TLX.AX

15.00%

12.9% | 49.0%

$7,347.30

$331.59

4.5%

TCON

10.00%

5.1% | -44.9%

-$4,488.86

$199.89

18.1%

VKTX

15.00%

34.2% | 295.7%

$44,355.19

-$2,684.04

1.7%

TERN

10.00%

8.0% | -14.3%

-$1,432.97

$184.90

11.7%





































Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext